Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?

Irene Giacomelli; Daniele Scartoni; Homan Mohammadi; William F. Regine; Michael D. Chuong

doi:10.21037/JGO.2017.06.14

Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?

Irene Giacomelli
, Daniele Scartoni
, Homan Mohammadi
, William F. Regine
, Michael D. Chuong

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of gastrointestinal oncology
Volume	8
DOIs	https://doi.org/10.21037/JGO.2017.06.14
State	Published - Aug 1 2017

Disciplines

Medicine and Health Sciences
Gastroenterology
Other Medical Specialties
Internal Medicine

Access to Document

10.21037/JGO.2017.06.14License: Unspecified

Cite this

@article{a0a9d9eb90ed439895d94aa35ef796bc,

title = "Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?",

author = "Irene Giacomelli and Daniele Scartoni and Homan Mohammadi and Regine, \{William F.\} and Chuong, \{Michael D.\}",

year = "2017",

month = aug,

day = "1",

doi = "10.21037/JGO.2017.06.14",

language = "American English",